结核病控制的新挑战: 出人意料的气溶胶检测新发现

doi:10.19982/j.issn.1000-6621.20240153

中国防痨杂志 ›› 2024, Vol. 46 ›› Issue (7): 739-742.doi: 10.19982/j.issn.1000-6621.20240153

结核病控制的新挑战: 出人意料的气溶胶检测新发现

李蒙, 高谦()

复旦大学基础医学院教育部、卫健委、医科院医学分子病毒学重点实验室/上海市重大传染病和生物安全研究院,上海200032

收稿日期:2024-04-18 出版日期:2024-07-10 发布日期:2024-07-01
通信作者: 高谦 E-mail:qiangao@fudan.edu.cn

New challenges in tuberculosis control: startling new findings on aerosol detection

Li Meng, Gao Qian()

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Science, Shanghai Medical College, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China

Received:2024-04-18 Online:2024-07-10 Published:2024-07-01
Contact: Gao Qian E-mail:qiangao@fudan.edu.cn

摘要/Abstract

摘要：

气溶胶是结核分枝杆菌传播的重要媒介,存在于气溶胶和痰液中的结核分枝杆菌的特性是否相同?近期在美国科学院院刊上发表了一篇气溶胶中结核分枝杆菌特征的论文,其研究结果颠覆了已有的认知。笔者将对此研究进行介绍,并提出基于此研究的一些思考。

关键词: 结核, 传染病控制, 气溶胶

Abstract:

Aerosols are vectors of Mycobacterium tuberculosis transmission. Are the characteristics of Mycobacterium tuberculosis in aerosols the same as those in sputum? A recent paper in the Proceedings of the National Academy of Sciences of the United States of America presents startling findings on Mycobacterium tuberculosis in aerosols. This research may pose new challenges for tuberculosis control. In this paper, we will briefly introduce this study and present some thoughts based on this research.

Key words: Tuberculosis, Communicable disease control, Aerosol

中图分类号:

李蒙, 高谦. 结核病控制的新挑战: 出人意料的气溶胶检测新发现[J]. 中国防痨杂志, 2024, 46(7): 739-742. doi: 10.19982/j.issn.1000-6621.20240153

Li Meng, Gao Qian. New challenges in tuberculosis control: startling new findings on aerosol detection[J]. Chinese Journal of Antituberculosis, 2024, 46(7): 739-742. doi: 10.19982/j.issn.1000-6621.20240153

参考文献 21

[1]	Roy CJ, Milton DK. Airborne transmission of communicable infection-the elusive pathway. N Engl J Med, 2004, 350(17):1710-1712. doi:10.1056/NEJMp048051.
[2]	Tellier R, Li Y, Cowling BJ, et al. Recognition of aerosol transmission of infectious agents: a commentary. BMC Infect Dis, 2019, 19(1):101. doi:10.1186/s12879-019-3707-y. pmid: 30704406
[3]	Patterson B, Wood R. Is cough really necessary for TB transmission?. Tuberculosis (Edinb), 2019, 117:31-35. doi:10.1016/j.tube.2019.05.003.
[4]	Patterson B, Bryden W, Call C, et al. Cough-independent production of viable Mycobacterium tuberculosis in bioaerosol. Tuberculosis (Edinb), 2021, 126:102038. doi:10.1016/j.tube.2020.102038.
[5]	Dinkele R, Gessner S, McKerry A, et al. Aerosolization of Mycobacterium tuberculosis by Tidal Breathing. Am J Respir Crit Care Med, 2022, 206(2):206-216. doi:10.1164/rccm.202110-2378OC.
[6]	Patterson B, Dinkele R, Gessner S, et al. Aerosolization of viable Mycobacterium tuberculosis bacilli by tuberculosis clinic attendees independent of sputum-Xpert Ultra status. Proc Natl Acad Sci U S A, 2024, 121(12):e2314813121. doi:10.1073/pnas.2314813121.
[7]	Fortune SM. The Titanic question in TB control: Should we worry about the bummock?. Proc Natl Acad Sci U S A, 2024, 121(14):e2403321121. doi:10.1073/pnas.2403321121.
[8]	Kamariza M, Shieh P, Ealand CS, et al. Rapid detection of Mycobacterium tuberculosis in sputum with a solvatochromic trehalose probe. Sci Transl Med, 2018, 10(430):eaam6310. doi:10.1126/scitranslmed.aam6310.
[9]	Dinkele R, Gessner S, Patterson B, et al. Persistent Mycobacterium tuberculosis bioaerosol release in a tuberculosis-endemic setting. medRxiv, 2024 [2024-04-17]. doi:10.1101/2024.04.02.24305196. Online ahead of print.
[10]	Voynow JA, Rubin BK. Mucins, mucus, and sputum. Chest, 2009, 135(2):505-512. doi:10.1378/chest.08-0412. pmid: 19201713
[11]	Johnson GR, Morawska L, Ristovski ZD, et al. Modality of human expired aerosol size distributions. J Aerosol Sci, 2011, 42(12):839-851.
[12]	Theron G, Limberis J, Venter R, et al. Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis. Nat Med, 2020, 26(9):1435-1443. doi:10.1038/s41591-020-0940-2. pmid: 32601338
[13]	Vilchèze C, Kremer L. Acid-Fast Positive and Acid-Fast Negative Mycobacterium tuberculosis: The Koch Paradox. Microbiol Spectr, 2017, 5(2). doi:10.1128/microbiolspec.TBTB2-0003-2015.
[14]	Pazos-Rojas LA, Cuellar-Sánchez A, Romero-Cerón AL, et al. The Viable but Non-Culturable (VBNC) State, a Poorly Explored Aspect of Beneficial Bacteria. Microorganisms, 2023, 12(1):39. doi:10.3390/microorganisms12010039.
[15]	赵雁林, 陈明亭. 中国结核病防治工作技术指南. 北京: 人民卫生出版社, 2021.
[16]	Malherbe ST, Shenai S, Ronacher K, et al. Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure. Nat Med, 2016, 22(10):1094-1100. doi:10.1038/nm.4177.
[17]	Beltran CGG, Heunis T, Gallant J, et al. Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy. Front Cell Infect Microbiol, 2020, 10:443. doi:10.3389/fcimb.2020.00443.
[18]	Malassez LC, Vignal W. Tuberculose zoogloéique (Forme ou espéce de tuberculose sans bacilles). Arch Physiol Norm Patholog, 1883, 2: 369-412.
[19]	Becerra MC, Huang CC, Lecca L, et al. Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study. BMJ, 2019, 367:l5894. doi:10.1136/bmj.l5894.
[20]	Yang C, Shen X, Peng Y, et al. Transmission of Mycobacterium tuberculosis in China: a population-based molecular epidemiologic study. Clin Infect Dis, 2015, 61(2):219-227. doi:10.1093/cid/civ255.
[21]	Ryckman TS, Dowdy DW, Kendall EA. Infectious and clinical tuberculosis trajectories: Bayesian modeling with case finding implications. Proc Natl Acad Sci U S A, 2022, 119(52):e2211045119. doi:10.1073/pnas.2211045119.

结核病控制的新挑战: 出人意料的气溶胶检测新发现

New challenges in tuberculosis control: startling new findings on aerosol detection

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 21

相关文章 15

编辑推荐

Metrics

本文评价

友情链接

[1]	李锦浩, 胡冬梅, 徐彩红. 结核病防治医务工作者开展预防性抗结核治疗工作意愿调查及影响因素分析[J]. 中国防痨杂志, 2025, 47(4): 398-407.
[2]	冯畏, 郑海伦, 孟炜丽, 罗萍. 2018—2023年北京市西城区结核病防治机构登记管理肺结核患者到位前漏报情况分析[J]. 中国防痨杂志, 2025, 47(4): 439-443.
[3]	郝明晓, 米洁, 许宗仪. 延续性护理路径在结核性脑膜炎患者中的应用效果分析[J]. 中国防痨杂志, 2025, 47(4): 477-481.
[4]	李敏, 姚宇珊, 乔海霞, 雷红. 肺结核与肠道菌群的相关性及治疗策略[J]. 中国防痨杂志, 2025, 47(4): 520-526.
[5]	胡一凡, 杜博平, 吴亚东, 朱传智, 张蓝月, 贾红彦, 孙琦, 潘丽萍, 张宗德, 李自慧. Mce4C蛋白参与结核分枝杆菌摄取利用胆固醇的实验研究[J]. 中国防痨杂志, 2025, 47(4): 444-453.
[6]	盛杰, 洪凯峰, 米尔扎提·艾沙, 唐伟, 地里下提·阿不力孜. 白细胞介素22和p38 MAPK信号通路抑制骨关节结核骨质破坏的作用机制研究[J]. 中国防痨杂志, 2025, 47(4): 454-459.
[7]	尚希钰, 张慧芳, 曹玉清, 熊一白, 纪鑫毓, 田雅欣, 李佳佳, 王倪, 马艳. 基于文献计量学的结核病中医药基础研究全球研究现状及热点分析[J]. 中国防痨杂志, 2025, 47(4): 482-497.
[8]	秦丽莉, 杨澄清, 麦洪珍, 徐齐峰, 薛新颖, 路希维. 结核后肺曲霉病的临床诊疗研究进展[J]. 中国防痨杂志, 2025, 47(4): 498-504.
[9]	罗莉, 罗林紫, 尹曲华, 周磊, 卢志斌, 丁衍, 肖阳宝. 淋巴结瘘型气管支气管结核的支气管镜下诊疗进展[J]. 中国防痨杂志, 2025, 47(4): 505-512.
[10]	宋云林, 布祖克拉·阿布都艾尼, 王桂荣, 张继园, 鲁晓擘. 钙结合蛋白S100A12与中性粒细胞胞外诱捕网形成在重症肺结核患者肺损伤中作用机制研究进展[J]. 中国防痨杂志, 2025, 47(4): 513-519.
[11]	中国防痨协会结核病控制专业分会, 中国防痨协会青年分会, 《中国防痨杂志》编辑委员会. 中国结核病数字服药依从性技术应用指南[J]. 中国防痨杂志, 2025, 47(4): 385-397.
[12]	吴璇, 张艳秋, 徐吉英, 孟丹, 孙定勇. 2019—2023年河南省肺结核合并糖尿病患者治疗转归影响因素分析[J]. 中国防痨杂志, 2025, 47(4): 425-431.
[13]	王颖超, 刘唯夷, 姬秀秀, 尚雪恬, 贾红彦, 张蓝月, 孙琦, 杜博平, 朱传智, 潘丽萍, 张宗德. 结核病患者外周血单个核细胞内环状RNA表达谱分析及诊断标识的鉴定[J]. 中国防痨杂志, 2025, 47(4): 460-470.
[14]	朱明智, 邵燕琴, 范大鹏, 刘立宾, 梅宾, 戴玲珊, 蔡龙. 尿液脂阿拉伯甘露聚糖抗原检测对肺外结核的诊断价值[J]. 中国防痨杂志, 2025, 47(4): 471-476.
[15]	李玉红, 梅金周, 苏伟, 阮云洲, 刘玉舒, 赵雁林, 刘小秋. 2015—2021年全国65岁及以上老年利福平耐药肺结核患者治疗转归及影响因素分析[J]. 中国防痨杂志, 2025, 47(4): 408-415.